CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nanjing Vazyme Biotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nanjing Vazyme Biotech Co Ltd
1-6F, East Section, Building C1-2
Hongfeng Science and Technology Park
Phone: +86 2585771179p:+86 2585771179 NANJING, JNG  210033  China Ticker: 688105688105
Business Summary
Nanjing Vazyme Biotech Co Ltd is China-based company principally engaged in life sciences, in vitro diagnostics, and biopharmaceuticals. Its products and services cover basic research reagents, high-throughput sequencing reagents, diagnostic raw materials, laboratory consumables and instruments, pharmaceutical R&D reagents, vaccine evaluation reagents and raw materials, etc. The company's products are mainly used in scientific research, high-throughput sequencing, molecular diagnostics, in vitro diagnostics, pharmaceutical, vaccine research and development, animal husbandry, and animal quarantine. The Company mainly conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2835 In vitro and in vivo diagnostic substances
3841 Surgical and medical instruments and apparatus
8731 Commercial physical and biological research
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager LinCao 45 5/1/2020 5/1/2020
Chief Financial Officer WenxinBi 48 5/1/2020 5/1/2020
Deputy General Manager, Director XiaomeiHu 57 5/1/2020 5/1/2020
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2,867 (As of 12/31/2024)
Outstanding Shares: 397,734,544 (As of 9/30/2025)
Shareholders: 7,726
Stock Exchange: SHA
Fax Number: +86 2585771171


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026